·¬ΗΡΙηΗψapp

Meeting Coverage

ATS

American Thoracic Society

BTK Inhibitor Likely to Get a Pass to Phase III in Uncontrolled Asthma

Phase II trial misses main goal, but drugmaker set to forge ahead

6 Hrs Ago
ATS over a photo of San Diego Convention Center in San Diego, CA

Latest ATS Meeting Coverage

Inhaled Amikacin Shows Promise for Untreated MAC Lung Infections

ARISE lays the ground work for registrational trial of Arikayce in earlier treatment setting

May 23, 2024
Anti-Epilepsy Drug Improves Sleep Apnea Symptoms in Mid-Stage Trial

AHI dipped by as much as 40% in patients who took sulthiame, but CPAP is still the gold standard

May 22, 2024
Tezepelumab Shows Potential for COPD, Negative Trial Notwithstanding

Asthma drug may benefit patients with blood eosinophil counts indicative of type 2 inflammation

May 22, 2024
Add-On Dupilumab for COPD Backed by Second Phase III Trial

NOTUS study confirms fewer exacerbations with biologic for patients on maximum inhaled therapy

May 21, 2024
Two Antibiotic Regimens Are Effective for M. Xenopi Pulmonary Infections

Patients benefited from clarithromycin or moxifloxacin plus rifampin/ethambutol

May 21, 2024
Acetaminophen Fails to Improve Mortality, Need for Organ Support in Sepsis

However, treated patients were less likely to develop ARDS, respiratory dysfunction

May 20, 2024
Beta-Blocker Fails to Prevent COPD Exacerbations

However, trial results don't affirm safety risks suggested by other studies

May 20, 2024
Finding Undiagnosed Asthma, COPD and Treating It Shows Benefit in Trial

Healthcare utilization for respiratory illness halved while quality of life, symptoms improved

May 20, 2024
Once-Promising Drug for Idiopathic Pulmonary Fibrosis Fails in Phase III Trial

An open-label extension trial of pamrevlumab was cancelled due to these results

May 20, 2024
Novel Drugs for IPF Improve Lung Function in Mid-Stage Trials

"These are among the two most exciting sets of results we've seen," researcher says

May 20, 2024
Lung Function Tests: End of Racial Adjustments Could Have Wide Impact

Millions in the U.S. may be reclassified, changing work eligibility, disability compensation

May 20, 2024
Gas Stove Use Linked to Indoor Pollutant Levels

Roundup of news on pollution exposures also delves into interstitial lung disease, sarcoidosis

May 25, 2023
Dual Phosphodiesterase Inhibitor Improved Lung Function in COPD Patients

Ensifentrine also reduced moderate-to-severe exacerbations

May 24, 2023
Biologic Reduced Cough, Phlegm in Severe, Uncontrolled Asthma

Separate trial analysis of tezepelumab showed no significant differences by sex

May 24, 2023